Loading…
Skin Beauty Solutions was cited for marketing multiple unapproved chemical peel drug products (including lactic acid 90%, glycolic acid 70%, and salicylic acid 30% formulations) in violation of sections 505(a) and 301(d) of the FD&C Act. The company made disease-treatment and body-function claims on its website (such as "clears acne & scars") that established these products as drugs requiring FDA approval before marketing. The FDA expressed concern that these potent chemical peels pose serious public health risks, including skin burns, wounds, scarring, and other injuries that have prompted emergency room visits and specialty dermatological care.